- 1. 15-Lipoxygenase, Reticulocyte Arachidonate
- [Encoded by human ALOX15 Gene, a putative mutator gene regulated by tumor-suppressor TP53, 661-amino acid 74.7 kD cytoplasmic Arachidonate 15-Lipoxygenase (Lipoxygenase Family) acts in leukotriene biosynthesis and is implicated in anti-inflammation, membrane remodeling, and cancer development or metastasis. It converts arachidonic acid to 15s-hydroperoxyeicosatetraenoic acid. (OMIM, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C0003692) =Amino Acid, Peptide, or Protein; Enzyme
| - 48. lipoid histiocytosis (classical phosphatide)
- [caused by deficiency of sphingomyelinase, resulting in accumulation of sphingomyelin in the reticuloendothelial system, mental and physical retardation, enlarged liver and spleen, anemia, and blindness. ( CSP )] (UMLS (CSP) C0028064) =Disease or Syndrome =Histiocytosis, Non-Langerhans-Cell;
Sphingolipidoses;
enzyme deficiency;
|
- 2. lip
- [upper or lower flesh margin of the mouth. ( CSP )] (UMLS (CSP) C0023759) =Body Location or Region =Buccal Cavity;
Body Part | - 49. LIPOID METABOL DIS NEC
- [ ] (UMLS (ICD9CM) C0029591) =Disease or Syndrome
|
- 3. Lip and Oral Cavity Cancer
- [A carcinoma arising in the lip or oral cavity. Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums. Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma. Lip carcinomas are usually basal cell or squamous cell carcinomas. — 2004 ( NCI )] (UMLS (NCI) C0220641) =Neoplastic Process ;
| - 50. lipolysis
- [decomposition or splitting up of fats or lipids. ( CSP )] (UMLS (CSP) C0023796) =Organism Function =fat metabolism;
|
- 4. Lip and Oral Cavity Cancer Stage 0
- [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (NCI) C0279270) =Neoplastic Process
| - 51. Lipoma
- [A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.(NCI)] (UMLS (ICPC) C0023798) (Lipoma; AZALEKO LIPOMA; Lipom; Lipoom; LIPOOMA, RASVAKASVAIN; Lipome; Lipom; lipoma baor; lipoma; Lipoma; LIPOM; Lipoma; Lipoma; LIPOM) =Neoplastic Process =Adipose Tissue Neoplasm; Diagnosis/Diseases Component; Integument;
|
- 5. Lip and Oral Cavity Cancer Stage I
- [Cancer that is no larger than 2 centimeters (about 1 inch) and has not spread to nearby lymph nodes. ( NCI )] (UMLS (NCI) C0279790) =Neoplastic Process
| - 52. LIPOMA INTRA-ABDOMINAL
- [ ] (UMLS (ICD9CM) C0153971) =Neoplastic Process
|
- 6. Lip and Oral Cavity Cancer Stage II
- [Cancer that is larger than 2 centimeters (about 1 inch) but smaller than 4 centimeters (about 2 inches) and has not spread to lymph nodes in the area. ( NCI )] (UMLS (NCI) C0279791) =Neoplastic Process
| - 53. LIPOMA INTRATHORACIC
- [ ] (UMLS (ICD9CM) C0153970) =Neoplastic Process
|
- 7. Lip and Oral Cavity Cancer Stage III
- [The cancer is larger than 4 centimeters (about 2 inches); or the cancer is any size but has spread to only one lymph node on the same side of the neck as the cancer. The lymph node that contains cancer is no larger than 3 centimeters (just over one inch). ( NCI )] (UMLS (NCI) C0279792) =Neoplastic Process
| - 54. LIPOMA NEC
- (UMLS (ICD9CM) C0023800) =Neoplastic Process
|
- 8. Lip and Oral Cavity Cancer Stage IV
- [The cancer has spread to tissues around the lip and oral cavity (the lymph nodes in the area may contain cancer); the cancer is any size and has spread to more than one lymph node on the same side of the neck as the cancer, to lymph nodes on one or both sides of the neck, or to any lymph node that is larger than 6 centimeters (larger than 2 inches); or the cancer has spread to other parts of the body. ( NCI )] (UMLS (NCI) C0279793) =Neoplastic Process
| - 55. Lipoma of Mediastinum
- [A benign adipose tissue neoplasm of the anterior, middle or posterior mediastinum. ( NCI )] (UMLS (NCI) C1334661) Lipoma of the Mediastinum;
Mediastinal Lipoma;
=Neoplastic Process |
- 9. Lip and Oral Cavity Neoplasm
- [new abnormal tissue of the mouth that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (NCI) C0026640) =Neoplastic Process ;
=Head and Neck Neoplasm;
Mouth Diseases;
Neoplasm of Oropharynx;
=Neoplasm of Salivary Gland;
Neoplasm of the Tongue;
Gingival Neoplasm;
Leukokeratosis of Oral Mucosa;
Lip Neoplasm;
Neoplasm of Palate;
Neoplasm of Salivary Gland;
Neoplasm of the Tongue | - 56. Lipoma of Mouth
- [A benign adipose tissue neoplasm of the oral cavity. It usually occurs within the lingual and buccal mucosa. ( NCI )] (UMLS (NCI) C1335120) Lipoma of Oral Cavity;
Lipoma of the Mouth;
Lipoma of the Oral Cavity;
Mouth Lipoma;
Oral Cavity Lipoma =Neoplastic Process ;
|
- 10. Lip and Oral Cavity Squamous Cell Carcinoma
- (UMLS (NCI) C0280297) =Neoplastic Process
| - 57. Lipoma of other skin and subcutaneous tissue
- [ ] (UMLS (ICD9CM) C0153969) =Neoplastic Process
|
- 11. Lip Neoplasm
- [A benign or malignant neoplasm involving the lip. ( NCI )] (UMLS (NCI) C0023761) =Neoplastic Process =DISEASES OF LIPS;
Lip and Oral Cavity Neoplasm | - 58. Lipoma of Parotid
- [A rare benign adipose tissue neoplasm of the major salivary gland. It predominantly occurs in males. ( NCI )] (UMLS (NCI) C1335360) Lipoma of Parotid Gland;
Lipoma of the Parotid;
Lipoma of the Parotid Gland;
Parotid Gland Lipoma;
Parotid Lipoma =Neoplastic Process ;
|
- 12. Lip SCC
- (UMLS (NCI) C0280302) =Neoplastic Process
| - 59. Lipoma of Pleura
- [A benign adipose tissue neoplasm of the pleural cavity. It may be purely intra-thoracic or extend to the chest wall. ( NCI )] (UMLS (NCI) C1335434) Lipoma of the Pleura;
Pleural Lipoma;
=Neoplastic Process ;
|
- 13. Lipan
- (UMLS (HL7) C1551919) Lipan Apache;
=Language =EasternApachean;
| - 60. Lipoma of Rectum
- [A benign adipose tissue neoplasm of the rectum. ( NCI )] (UMLS (NCI) C1335684) Lipoma of the Rectum;
Rectal Lipoma =Neoplastic Process ;
|
- 14. lipase
- [non-EC general term; note that individual lipid hydrolases have not been treed under this term. ( CSP )] (UMLS (CSP) C0023764) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme =Carboxylic Ester Hydrolases;
Ester Hydrolase;
carboxylesterase;
Inactive Ingredient Preparations =Pancrelipase;
LIPASE 8000 UNT;
LIPASE 4000 UNT;
LIPASE 5000 UNT;
LIPASE 12000 UNT;
LIPASE 16000 UNT;
LIPASE 20000 UNT;
LIPASE 4500 UNT;
LIPASE 24000 UNT;
LIPASE 6000 UNT;
LIPASE 10000 UNT;
LIPASE 27.5 MG;
LIPASE 75 MG;
LIPASE 6500 UNT;
LIPASE 25000 UNT;
LIPASE 32000 UNT;
LIPASE 30000 UNT;
LIPASE 1000 UNT;
LIPASE 2000 UNT;
LIPASE 25 MG;
LIPASE 650 UNT;
LIPASE 0 NS;
LIPASE 16800 UNT/07GM;
LIPASE 175 MG;
LIPASE 6750 UNT;
| - 61. Lipoma of skin and subcutaneous tissue of face
- [ ] (UMLS (ICD9CM) C0153968) =Neoplastic Process
|
- 15. LIPASE
- [A quantitative measurement of the amount of triacylglycerol lipase present in a sample. ( NCI )] (UMLS (NCI) C0523940) =Laboratory Procedure
| - 62. Lipoma of Small Bowel
- [A rare benign adipose tissue neoplasm of the small intestine. It usually arises from the submucosa and occasionally protrudes into the lumen. ( NCI )] (UMLS (NCI) C1336001) Lipoma of Small Intestine;
Lipoma of the Small Bowel;
Lipoma of the Small Intestine;
Small Bowel Lipoma;
Small Intestinal Lipoma =Neoplastic Process |
- 16. Lipemia
- [An observation used to describe the Lipemia Index of the specimen. It is recommended to use the optical turbidity at 600 nm (in absorbance units). ( HL7V3.0 )] (UMLS (HL7) C1553189) =Idea or Concept =ActSpecObsInterferenceCode;
| - 63. Lipoma of Spermatic Cord
- [A benign adipose tissue neoplasm of the spermatic cord. This is the most common tumor amongst the benign paratesticular lesions. ( NCI )] (UMLS (NCI) C0153972) =Neoplastic Process
|
- 17. Lipiarmycin
- (UMLS (NCI) C0065023) =Carbohydrate
| - 64. Lipoma of Spinal Cord
- [A benign adipose tissue neoplasm of the spinal cord. It is usually associated with dysraphism in which the intraspinal component communicates with a subcutaneous lipoma through a defect in the posterior elements of the spine. Non-dysraphic intramedullary spinal cord lipomas are very rare. ( NCI )] (UMLS (NCI) C0347446) =Neoplastic Process
|
- 18. Lipiarmycin A3
- (UMLS (NCI) C0125918) =Carbohydrate
| - 65. Lipoma of Tendon Sheath
- [A benign tumor, composed of mature adipocytes, that arises within the tendon sheath. ( NCI )] (UMLS (NCI) C1336703) Lipoma of the Tendon Sheath;
Tendon Sheath Lipoma;
=Neoplastic Process ;
|
- 19. lipid
- [any of a class of hydrophobic biochemicals including fats, long- chain fatty acids, steroids, oils, and waxes. ( CSP )] (UMLS (CSP) C0023779) =Lipid =hydrocarbon;
Lipids and Antilipemic Agents =fat;
Fatty Acid;
glyceride;
glycolipid;
lipofuscin;
membrane lipid;
oil;
phosphatide;
sphingolipid;
sterol;
terpene;
blood lipid;
oxidized lipid;
sterol ester;
fat;
Fatty Acid;
Fatty Alcohols;
glyceride;
Lipoprotein;
membrane lipid;
oil;
WAX;
LIPID,STRUCTURED (FROM PALM KERNEL OIL);
| - 66. Lipoma of the Tongue
- [A benign adipose tissue neoplasm of the tongue. ( NCI )] (UMLS (NCI) C0238467) =Neoplastic Process
|
- 20. lipid bilayer membrane
- [two layers of phospholipids, forming the basic structure of a biological membrane; bilayer systems are frequently studied as models of biological membranes. ( CSP )] (UMLS (CSP) C0023768) =Cell Component =cell membrane;
artificial membrane | - 67. Lipoma of the Tonsil
- [A benign adipose tissue neoplasm of the tonsils. ( NCI )] (UMLS (NCI) C1336764) Lipoma of Tonsil;
Tonsil Lipoma;
Tonsillar Lipoma;
=Neoplastic Process ;
|
- 21. Lipid Binding
- [Lipid Binding is the molecular interaction between a lipid molecule and a macromolecule (usually protein) for transport, catalysis, localization, or modification of function. ( NCI )] (UMLS (NCI) C1148636) =Molecular Function ;
| - 68. Lipomatous Hamartoma
- (UMLS (NCI) C1302836) =Disease or Syndrome
|
- 22. lipid biosynthesis
- [anabolic formation of lipid compounds in organisms or living cells; this includes fats, long-chain fatty acids, and oils. ( CSP )] (UMLS (CSP) C1563744) lipogenesis;
=Organism Function; ;
=anabolism;
fat metabolism =fatty acid biosynthesis | - 69. Lipomatous Hemangiopericytoma
- [A benign hemangiopericytoma with lipomatous differentiation. ( NCI )] (UMLS (NCI) C1334402) =Neoplastic Process; ;
|
- 23. Lipid Cell Neoplasm of Ovary
- [An ovarian tumor in which the vast majority of the cells (more than 90% of the tumor cells) resemble steroid hormone-secreting cells. It usually presents with androgenic manifestations. Approximately one-third of the cases follow a malignant clinical course. ( NCI )] (UMLS (NCI) C0334412) =Neoplastic Process
| - 70. lipomucopolysaccharidosis
- [ ] (UMLS (CSP) C0023806) =Disease or Syndrome
|
- 24. lipid mediator
- [ ] (UMLS (CSP) C0599745) =Biologically Active Substance ;
| - 71. lipooligosaccharide
- [ ] (UMLS (CSP) C0065036) =Carbohydrate; Lipid ;
|
- 25. Lipid metabolism disorder
- [condition in which there is a deviation or interruption in the processing of lipids in the body: synthesis, absorption, transport, storage, and utilization.(CSP)] (UMLS (ICPC) C0154251) (Lipid metabolism disorder; LIPIDOETAKO METABOLISMO NAHASKETA; Forstyrrelser i lipid-stofskiftet; Vetstofwisselingsstoornissen; RASVA-AINEENVAIHDUNNAN HAIRIO; Dyslipidemies; Fettstoffwechselstoerungen; hiperlipidemia.hiperxolesterolemia; zsiranyagcsere-zavar; Disturbi del metabolismo lipidico; FORSTYRR VED LIPID-STOFFSKIFTET; Alteracoes do metabolismo lipidico; Enf metabolismo lipidico; RUBBNINGAR I LIPIDOMSATTNINGEN) =Disease or Syndrome =Metabolic Disease; ENDOCRINE, METABOLIC AND NUTRITIONAL; Diagnosis/Diseases Component; =fatty liver; hyperlipemia; lipodystrophy; xanthelasmatosis; inborn lipid/lipoprotein disorder; hypolipemia; lipoprotein disorder; Lipogranuloma
| - 72. lipophilicity
- [Lipophilicity represents the affinity of a molecule or a moiety for a lipophilic environment. It is commonly measured by its distribution behavior in a biphasic system, either liquid-liquid or solid-liquid, or thin-layer chromatography system. (from Pure Appl. Chem., 70, 1129-1143 (1998)) ( NCI )] (UMLS (CSP) C0598631) =Quantitative Concept ;
|
- 26. lipid peroxide
- [peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen; results in the destruction of the original lipid leading to the loss of integrity of the membranes. ( CSP )] (UMLS (CSP) C0023776) =Lipid =oxidized lipid;
| - 73. lipophobicity
- [ ] (UMLS (CSP) C0598632) =Quantitative Concept ;
|
- 27. lipid protein complex (nonblood)
- [protein lipid complexes which are not blood components. ( CSP )] (UMLS (CSP) C0597077) =Amino Acid, Peptide, or Protein; Biologically Active Substance =gene product;
=CHG;
| - 74. lipopolysaccharide
- [lipid-containing polysaccharides which are endotoxins and important group-specific antigens; often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. ( CSP )] (UMLS (CSP) C0023810) =Lipid =Mitogen;
bacterial polysaccharide |
- 28. lipid raft
- [localized regions of elevated cholesterol and glycosphingolipid content within cell membranes; implicated in cellular processes such as membrane sorting, vesicle transport and signal transduction. ( CSP )] (UMLS (CSP) C1167250) =Cell Component =cell membrane;
| - 75. Lipopolysaccharide Biosynthesis
- [The chemical reactions and pathways resulting in the formation of lipopolysaccharides, any of a group of related, structurally complex components of the outer membrane of Gram-negative bacteria. [GOC:ai] ( GO )] (UMLS (NCI) C1157209) Lipopolysaccharide Biosynthesis Pathway;
=Molecular Function |
- 29. lipid solubility
- [quality or fact of being soluble in any of a class of hydrophobic biochemicals including fats, long- chain fatty acids, steroids, oils, and waxes; susceptibility of being dissolved by a lipid. ( CSP )] (UMLS (CSP) C0596844) =Quantitative Concept =solubility;
| - 76. Lipoprotein
- [An important class of serum proteins in which a spherical hydrophobic core of triglycerides or cholesterol esters surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Classified according to density: chylomicrons, large low density particles, very low density, low density and high density species. Important in lipid transport, especially cholesterol transport in the blood stream. Abnormalities in lipoprotein metabolism have been implicated in certain heart diseases. ( NCI )] (UMLS (NCI) C0023820) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=lipid;
gene product;
Biological Macromolecular Agents;
=Surfactants;
Lung Surfactant |
- 30. lipid storage myopathy associated with carnitine deficiency
- [ ] (UMLS (CSP) C0598585) =Disease or Syndrome
| - 77. lipoprotein disorder
- [deviation or interruption in the processing of lipoproteins in the body: its biosynthesis, absorption, transport, storage, and utilization. ( CSP )] (UMLS (CSP) C0596848) =Disease or Syndrome =blood protein disorder;
Alteracoes do metabolismo lipidico =hyperlipoproteinemia;
hypolipoproteinemia;
|
- 31. lipid structure
- [ ] (UMLS (CSP) C0596845) =Lipid =chemical structure;
| - 78. lipoprotein lipase inhibitor
- [ ] (UMLS (CSP) C0598387) =Pharmacologic Substance
|
- 32. Lipid Trafficking
- [movement of lipids through a biological system; can be across cell membranes and epithelial layers and also can occur within intracellular compartments and extracellular compartments. ( CSP )] (UMLS (NCI) C0596846) =Cell Function =biological transport;
=fatty acid transport | - 79. lipoprotein metabolism disorder
- [ ] (UMLS (CSP) C0494345) =Disease or Syndrome
|
- 33. Lipid-Laden Macrophage
- (UMLS (NCI) C0333738) =Cell
| - 80. Liposarcoma
- [malignant tumor derived from primitive or embryonal lipoblastic cells; may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid, round-celled, or pleomorphic, usually in association with a rich network of capillaries; recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. ( CSP )] (UMLS (NCI) C0023827) =Neoplastic Process =connective tissue cancer;
Adipose Tissue Neoplasm;
Connective Tissue Sarcoma;
=Liposarcoma, Myxoid;
|
- 34. Lipid-Rich Carcinoma
- [A carcinoma characterized by the presence of malignant epithelial cells with clear cytoplasm which contains neutral lipids. A representative example is the lipid-rich breast carcinoma. ( NCI )] (UMLS (NCI) C0334318) =Neoplastic Process
| - 81. Liposarcoma Metastatic
- [A liposarcoma that has metastasized to a secondary site. ( NCI )] (UMLS (NCI) C0855059) Metastatic Liposarcoma =Neoplastic Process
|
- 35. Lipiodol
- (UMLS (NCI) C0947677) =Lipid; Indicator, Reagent, or Diagnostic Aid ;
| - 82. Liposarcoma Nonmetastatic
- [A liposarcoma that has not metastasized to secondary sites. ( NCI )] (UMLS (NCI) C0855060) Non-Metastatic Liposarcoma;
Primary Liposarcoma;
=Neoplastic Process |
- 36. lipitor
- [ ] (UMLS (CSP) C0593906) =Organic Chemical; Pharmacologic Substance
| - 83. Liposarcoma of Mediastinum
- [A malignant adipose tissue neoplasm of the anterior, middle or posterior mediastinum. ( NCI )] (UMLS (NCI) C1334663) Liposarcoma of the Mediastinum;
Mediastinal Liposarcoma;
=Neoplastic Process |
- 37. Lipo-Hepin
- (UMLS (NCI) C0700893) =Carbohydrate; Pharmacologic Substance
| - 84. Liposarcoma of Ovary
- [A malignant adipose tissue neoplasm of the ovary. ( NCI )] (UMLS (NCI) C1335165) Liposarcoma of the Ovary;
Ovarian Liposarcoma;
=Neoplastic Process |
- 38. Lipo-Lutin
- (UMLS (NCI) C0701118) =Steroid; Pharmacologic Substance; Hormone
| - 85. Liposarcoma Recurrent
- [The reemergence of a malignant adipose tissue neoplasm after a period of remission. ( NCI )] (UMLS (NCI) C0855061) Recurrent Liposarcoma;
Relapsed Liposarcoma;
=Neoplastic Process |
- 39. Lipoadenoma
- [An adenoma in which the neoplastic epithelial cells are admixed with adipose tissue cells. ( NCI )] (UMLS (NCI) C0334325) =Neoplastic Process
| - 86. liposomal
- [single or multilaminar vesicles (made from lecithins or other lipids) that can be used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer; also used to study membranes and membrane proteins. ( CSP )] (UMLS (NCI) C0023828) =Cell Component; Lipid ;
=DDS;
membrane |
- 40. lipoaminoacid
- [ ] (UMLS (CSP) C0598433) =Amino Acid Sequence; Lipid
| - 87. liposomal lurtotecan
- [A liposome-encapsulated formulation of lurtotecan with antineoplastic activity. Lurtotecan, a semisynthetic analogue of camptothecin, selectively stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex during S phase of the cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-stranded DNA breaks. This ultimately results in an inhibition of DNA replication, inducing double-stranded DNA breakages, obstruction of RNA and protein synthesis and triggering apoptosis. Furthermore, this agent also stimulates degradation of topoisomerase I, likely mediated through ubiquitin-proteasomal pathway. Liposomal delivery of lurtotecan improves its penetration and delivery into tumors while lowering systemic side effects. ( NCI )] (UMLS (NCI) C0796638) liposome, lurtotecan;
Lurtotecan Liposome;
=Organic Chemical; Pharmacologic Substance ;
|
- 41. lipoate
- [ ] (UMLS (CSP) C0178731) =Organic Chemical; Vitamin
| - 88. Liposomal NDDP
- [A synthetic liposomal formulation of bis-neodecanoate diaminocyclohexane platinum (NDDP) with potential antineoplastic activity. Liposomal NDDP is a third-generation antineoplastic platinum complex, an analogue of cisplatin. After displacement of the 2 long-chain aliphatic leaving groups (neodecanoic acid), platinum diaminocyclohexane (DACH) complexes become highly reactive and able to alkylate macromolecules, forming both inter- and intra-strand DNA crosslinkings, thereby inhibiting DNA synthesis and resulting in cytotoxicity. The DACH moiety of this agent appears to inhibit DNA repair mechanism, which overcome the limits observed in other platinum-based therapies. In addition, the liposomal encapsulation improves the bioavailability of NDDP, increases delivery to tumor tissues and reduces its toxicity profile. ( NCI )] (UMLS (NCI) C0125061) =Organic Chemical; Pharmacologic Substance ;
|
- 42. lipoatrophic diabetes mellitus
- [Congenital disorders, usually autosomal recessive, characterized by severe generalized lack of ADIPOSE TISSUE, extreme INSULIN RESISTANCE, and HYPERTRIGLYCERIDEMIA. ( MSH )] (UMLS (CSP) C0221032) =Disease or Syndrome ;
| - 89. Liposome-Encapsulated Paclitaxel
- [A liposome-encapsulated formulation of paclitaxel, a taxoid compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic property. Paclitaxel binds to tubulin and interferes with the assembly/disassembly dynamics of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis via inactivation of the apoptosis inhibitor, B-cell Leukemia 2 (Bcl-2) protein. Paclitaxel liposome formulation potentially enhances delivery of higher doses of paclitaxel to the target tissues and exhibits lower systemic toxicity. ( NCI )] (UMLS (NCI) C0935868) Paclitaxel Liposome =Organic Chemical; Pharmacologic Substance
|
- 43. lipoatrophy
- [ ] (UMLS (CSP) C1280433) =Disease or Syndrome
| - 90. Liposyn
- (UMLS (NCI) C0065066) =Lipid
|
- 44. Lipoblast
- [A connective tissue cell that develops into a fat cell. ( NCI )] (UMLS (NCI) C0225320) =Cell
| - 91. Lipothrixviridae
- [Family of enveloped, lipid-containing, filamentous DNA viruses that infect ARCHAEA. ( MSH )] (UMLS (CSP) C0598319) =Virus
|
- 45. lipodystrophy
- [collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat; includes total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy. ( CSP )] (UMLS (CSP) C0023787) =Disease or Syndrome =Skin Diseases, Metabolic;
Alteracoes do metabolismo lipidico =Diabetes Mellitus, Lipoatrophic;
| - 92. lipoxin
- [Trihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation. ( MSH )] (UMLS (CSP) C0599689) =Lipid; Biologically Active Substance
|
- 46. lipofuscin
- [naturally occurring lipid pigment with histochemical characteristics similar to ceroid; it accumulates in various normal tissues and apparently increases in quantity with age. ( CSP )] (UMLS (CSP) C0023789) =Lipid; Biologically Active Substance ;
=lipid;
pigment | - 93. lipreading
- [determining what a person is saying by watching the movement of their lips. ( CSP )] (UMLS (CSP) C0023844) =Activity =deaf aid;
|
- 47. lipogenesis inhibitor
- [any substance or agent which suppresses, prevents or opposes the biosynthesis of lipids in organisms or living cells. ( CSP )] (UMLS (CSP) C0596847) =Chemical Viewed Functionally =inhibitor/antagonist;
| - 94. LIPSTICK
- [A waxy solid, usually colored cosmetic, in stick form for the lips. ( NCI )] (UMLS (NCI) C0304638) =Substance ;
|
home
